By Mill Chart
Last update: Nov 8, 2023
Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if INTER PARFUMS INC (NASDAQ:IPAR) is suited for growth investing. Investors should of course do their own research, but we spotted INTER PARFUMS INC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.
ChartMill assigns a Fundamental Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple fundamental indicators and properties.
IPAR gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 39 industry peers in the Personal Care Products industry. While IPAR has a great profitability rating, there are some minor concerns on its financial health. IPAR is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make IPAR suitable for growth investing!
For an up to date full fundamental analysis you can check the fundamental report of IPAR
More ideas for growth investing can be found on ChartMill in our Lois Navellier screen.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
INTER PARFUMS INC
NASDAQ:IPAR (4/19/2024, 3:04:36 PM)
After market: 127.88 0 (0%)127.88
+3.96 (+3.2%)
Inter Parfums (IPAR) declares a $0.75/share quarterly dividend, a 20% increase from the previous dividend, with a forward yield of 2.07%.
Inter Parfums (IPAR) Q4 profit misses estimates, issues soft 2024 guidance. Read more here.
Colgate-Palmolive stock had its Relative Strength Rating climb to 72 Wednesday -- a nice improvement, but shy of the preferred 80-plus score.
Inter Parfums expects a 12% increase in net sales and an 8% increase in earnings per share in 2024, driven by new fragrance launches and sales growth from...
e.l.f. Beauty saw its IBD SmartSelect Composite Rating jump to 96 Wednesday, up from 92 the day before.